Inhibrx Biosciences, Inc. (INBX)
Across 9 earnings reports since Aug 13, 2024, Inhibrx Biosciences, Inc. (INBX) has a clear post-earnings pattern. It moves ±4.50% on average after reporting and finishes higher 33.3% of the time. Its largest post-earnings gain was +10.89% (May 14, 2025) and its largest decline was -9.12% (Aug 13, 2026). The next earnings report is predicted for 2026-11-13 (estimated).
Earnings reactions
How INBX moved on each past earnings report.
Earnings Impact
Total Earnings
9
Avg Abs. Movement
±4.50%
Positive %
33.3%
Negative %
66.7%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 13, 2026 | ☽ POST | -9.12% | open_in_new |
| May 14, 2026 | ☽ POST | -6.53% | open_in_new |
| Mar 19, 2026 | ☽ POST | -6.09% | open_in_new |
| Nov 14, 2025 | ☽ POST | -2.25% | open_in_new |
Earnings Count
9
Total earnings in dataset
Avg Abs. Movement
±4.50%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260908 | open_in_new SEC.gov |
| 4 | 20260908 | open_in_new SEC.gov |
| 4 | 20260908 | open_in_new SEC.gov |
| 4 | 20260908 | open_in_new SEC.gov |
| 8-K | 20260908 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260813 | open_in_new SEC.gov |
Frequently asked about INBX earnings
When does Inhibrx Biosciences, Inc. report earnings next? expand_more
Inhibrx Biosciences, Inc. (INBX)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does INBX stock move after earnings? expand_more
Over 9 reports, INBX has moved an average of ±4.50% the session after earnings, closing higher 33.3% of the time.
What was INBX's biggest post-earnings move? expand_more
INBX's largest post-earnings gain on record was +10.89% on May 14, 2025, and its largest decline was -9.12% on Aug 13, 2026.
Where can I find Inhibrx Biosciences, Inc.'s SEC filings? expand_more
All of Inhibrx Biosciences, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right